The Jamie Kern Lima Show

Your Menopause Masterclass Pt 2: How to Lose Belly Fat, Sleep Better & Stop Suffering Now! Dr. Mary Claire Haver

January 6, 2026

Key Takeaways Copied to clipboard!

  • Hormonal chaos during perimenopause (bouncing estrogen/progesterone) leads to flatlining levels in postmenopause, and many common symptoms like anxiety, weight gain, and sleep disturbance are often misdiagnosed without checking underlying hormone levels. 
  • Nine out of ten doctors are likely not well-trained in hormones or Hormone Replacement Therapy (HRT), leading many women to be treated for symptoms rather than the root cause of hormonal imbalance. 
  • Systemic oral estrogen carries a slightly increased risk of blood clots compared to non-oral (transdermal) formulations like patches or gels, which is a crucial distinction for patient safety. 
  • Transdermal (patch, cream, gel) Hormone Replacement Therapy (HRT) options avoid the liver processing and potential clotting risks associated with oral estrogen, though oral is the cheapest option. 
  • If a woman is on estrogen HRT and has a uterus, taking a progestogen is mandatory for uterine lining protection, making the absence of progesterone a major red flag. 
  • Testosterone in women, while not FDA-approved for most indications, can be beneficial off-label for low libido, mood, mental clarity, stamina, and increasing muscle mass to combat frailty and osteoporosis. 

Segments

Hormone Changes Explained
Copied to clipboard!
(00:00:33)
  • Key Takeaway: Testosterone is the precursor hormone necessary for the body to produce estradiol (estrogen).
  • Summary: Females have four times the amount of testosterone as estradiol during reproductive years, and testosterone is essential as it converts into estradiol. During perimenopause, the system becomes chaotic, leading to estrogen and progesterone fluctuations before they eventually flatline in postmenopause. The average age for menopause is 46 to 55, preceded by 7 to 10 years of perimenopause.
Symptoms Misdiagnosis
Copied to clipboard!
(00:01:02)
  • Key Takeaway: Symptoms like anxiety, bloating, weight gain, and heart issues can stem from off-hormone levels, yet millions are treated for symptoms without testing for the underlying cause.
  • Summary: Many women experience symptoms that mimic mental health issues or other conditions when their hormones are imbalanced. Doctors often treat these symptoms with multiple medications without performing blood work to rule out hormonal causes. This results in millions of people being treated for symptoms rather than addressing the root hormonal imbalance.
Finding Informed Care
Copied to clipboard!
(00:03:06)
  • Key Takeaway: Many general practitioners may not be sufficiently trained in menopause or HRT, necessitating proactive patient inquiry or seeking specialized providers.
  • Summary: General practitioners may lack the necessary knowledge to adequately help women experiencing perimenopause symptoms. Women are encouraged to seek out certified providers, such as those listed by the Menopause Society, or utilize affordable telemedicine options if local care is insufficient. Patients should be prepared to ask specific questions to gauge a clinician’s expertise in HRT.
HRT Options and Costs
Copied to clipboard!
(00:05:01)
  • Key Takeaway: Hormone Replacement Therapy options are numerous, including topical estrogen for skin health and vaginal symptoms, which can be affordable even out-of-pocket.
  • Summary: Vaginal estrogen cream is FDA-approved for symptoms like dryness and is often covered by insurance or costs as little as $10-$15 monthly out-of-pocket. Topical estrogen applied to the skin can help with collagen appearance, though compounded versions are typically used for facial application. Pelvic floor physical therapy is also highlighted as a crucial, often overlooked, treatment.
Benefits of Optimal Hormones
Copied to clipboard!
(00:06:19)
  • Key Takeaway: Achieving optimal hormone balance can lead to significant life improvements, making the patient feel better than they did in their 30s and 40s.
  • Summary: When hormones are optimized through therapy, women report feeling excited every morning, experiencing better relationships, improved business performance, and enhanced personal well-being. While health is possible without HRT, the guest asserts that achieving one’s best self is significantly harder without it.
Estrogen’s Systemic Impact
Copied to clipboard!
(00:07:45)
  • Key Takeaway: Estrogen deficiency impacts nearly every organ system, contributing to issues like increased cardiovascular risk, visceral fat accumulation, and musculoskeletal pain.
  • Summary: Low estrogen is linked to increased LDL cholesterol, new onset pre-diabetes, and a rise in cardiovascular disease risk after menopause. Visceral fat wrapping around organs is driven by estrogen loss, and 80% of women experience musculoskeletal pain, which can be debilitating. Libido loss and relationship strain are also common, treatable symptoms of this transition.
HRT Myths Debunked
Copied to clipboard!
(00:03:21)
  • Key Takeaway: The myths that HRT is dangerous for most women, only treats severe hot flashes, requires expensive compounding, or is inherently costly are untrue.
  • Summary: HRT is not inherently dangerous for the majority of women, and it addresses far more than just hot flashes, including quality of life issues. Affordable bioidentical HRT options are available for as little as $25-$30 per month through clinicians willing to help patients find the right pharmacy. Clinicians steering patients exclusively toward compounded pellets may have a financial incentive, which warrants patient caution.
Questions for Your Doctor
Copied to clipboard!
(00:03:45)
  • Key Takeaway: Patients should call ahead to ask prospective clinicians three key questions regarding their willingness to discuss HRT and the percentage of patients receiving it.
  • Summary: Patients should inquire if the clinician is willing to discuss HRT and what percentage of their patients receive it, noting that 100% is a red flag, but less than 25% might also be concerning. They should also ask if the doctor will offer all options or steer them toward one specific product. Bringing The Menopause Society guidelines to the appointment can also help educate the provider.
Testing for Menopause Status
Copied to clipboard!
(00:04:26)
  • Key Takeaway: Diagnosing full menopause is straightforward using FSH (above 50) and estradiol (below 20) blood tests, but perimenopause diagnosis relies more on clinical symptoms due to hormonal fluctuation.
  • Summary: A single blood test is unreliable for diagnosing perimenopause because hormones are constantly fluctuating; however, FSH consistently above 50 and estradiol below 20 confirms postmenopausal status. For women still cycling, checking an estradiol to FSH ratio on day three of the cycle can offer a clue, but the Dutch urine test is considered too expensive and outside traditional medical recognition for routine use.
Systemic HRT Delivery Methods
Copied to clipboard!
(00:05:08)
  • Key Takeaway: Systemic estrogen delivery via oral pills is processed by the liver, potentially increasing clotting factors, whereas non-oral methods like patches or gels bypass this hepatic first pass.
  • Summary: Systemic HRT comes in oral (pills) and non-oral forms (patch, cream, gel, spray, trochee, pellet). Oral estrogen causes the liver to increase SHBG and slightly increase clotting factors, which is a concern for women with clotting predispositions. Non-oral methods avoid this liver processing, offering a potentially safer route for systemic hormone replacement.
HRT Formulation Cost Comparison
Copied to clipboard!
(00:59:31)
  • Key Takeaway: Non-oral HRT formulations like patches and gels are significantly more expensive than the $2/month oral estrogen option.
  • Summary: Non-oral estrogen formulations (patch, cream, gel, pellet) are preferred by some to avoid liver processing, but the cheapest option remains oral estrogen at about $2 per month. Patches can cost $20-$25 monthly with coupons, while sprays and gels range from $75 to over $200 monthly without generic options.
HRT Candidacy Contraindications
Copied to clipboard!
(01:03:26)
  • Key Takeaway: Estrogen HRT candidacy is primarily restricted by active estrogen/progesterone-fed tumors, severe liver disease, and current blood clot treatment.
  • Summary: Most candidacy concerns revolve around estrogen; individuals with tumors fed by estrogen or progesterone, or severe liver disease, are generally not candidates. Those actively being treated for a blood clot should avoid oral estrogen but may be candidates for transdermal estrogen after treatment concludes.
Progesterone Necessity and Sleep Benefits
Copied to clipboard!
(01:06:06)
  • Key Takeaway: Progesterone is mandatory for women with a uterus taking estrogen to prevent uterine lining overgrowth, and it is highly effective for improving sleep, even post-hysterectomy.
  • Summary: If a woman has a uterus, progesterone is mandatory when taking estrogen to protect the uterine lining from becoming cancerous. Oral micronized progesterone, costing about $10 a month, is recommended for sleep benefits even for women without a uterus. Being on estrogen without progesterone is a significant red flag indicating a lack of endocrinological understanding.
Testosterone Use and Cost
Copied to clipboard!
(01:08:37)
  • Key Takeaway: Testosterone is highly effective for low libido and is being used off-label to support muscle mass, mental clarity, and mood in menopausal women.
  • Summary: Testosterone is proven effective for hypoactive sexual desire disorder (HSDD) and is being recommended off-label for low muscle mass, which helps decrease osteoporosis risk. Oral testosterone is avoided due to liver impact; Androgel is used off-label transdermally for a steady state, aiming to restore levels seen in a woman’s 30s. Testosterone is never covered by insurance and costs about $10 a month with workarounds like GoodRX.
Compounded vs. FDA-Approved Drugs
Copied to clipboard!
(01:11:40)
  • Key Takeaway: FDA-approved medications have high formulation accuracy (98%), whereas compounding pharmacies showed up to a 30% discrepancy in tested hormone therapy amounts.
  • Summary: FDA-approved medications come from large-scale pharmacies and are highly consistent, while compounding involves case-by-case mixing, which historically led to human error and inconsistency. An FDA check five years prior found up to a 30% discrepancy in formulation amounts in the top 12 compounding pharmacies tested, highlighting a risk in consistency.
HRT Risk Reassessment Post-WHI
Copied to clipboard!
(01:17:16)
  • Key Takeaway: The benefits of HRT, especially when started early in menopause, outweigh the risks, as the initial cancer link was based on an older population and a specific progestogen.
  • Summary: Starting HRT within the first 10 years of menopause offers a 50% per year decrease in cardiovascular disease risk and always protects bones against osteoporosis. The initial fear stemmed from the Women’s Health Initiative (WHI) study, which averaged patient age at 63 and used a specific progestogen (Provera) linked to a slight, non-statistically significant risk increase. HRT protects against urogenital issues and helps delay the onset of dementia and frailty, addressing the gender health gap.